Sales & Marketing Sponsored Investing in healthcare futures: Elia Stupka and Paul Tunnah Angelini Ventures is an new investment fund seeking companies transformational in healthcare.
News Boehringer raises hope of oral drug for diabetic eye disease Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face